Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Bioadaptives (BDPT) Equity Ratio (2019 - 2025)

Bioadaptives' Equity Ratio history spans 7 years, with the latest figure at 9.43 for Q4 2025.

  • Quarterly results put Equity Ratio at 9.43 for Q4 2025, down 68.68% from a year ago — trailing twelve months through Dec 2025 was 9.43 (down 68.68% YoY), and the annual figure for FY2025 was 9.43, down 68.68%.
  • Equity Ratio for Q4 2025 was 9.43 at Bioadaptives, up from 11.78 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 3.48 in Q3 2023 to a low of 213.82 in Q2 2024.
  • The 5-year median for Equity Ratio is 15.03 (2023), against an average of 33.55.
  • The sharpest move saw Equity Ratio tumbled 1018.35% in 2024, then skyrocketed 97.89% in 2025.
  • Year by year, Equity Ratio stood at 7.36 in 2021, then crashed by 428.79% to 38.9 in 2022, then skyrocketed by 59.3% to 15.83 in 2023, then skyrocketed by 64.7% to 5.59 in 2024, then tumbled by 68.68% to 9.43 in 2025.
  • According to Business Quant data, Equity Ratio over the past three periods came in at 9.43, 11.78, and 4.52 for Q4 2025, Q3 2025, and Q2 2025 respectively.